Raymond James Financial’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
Raymond James Financial's CLBT Position: Q3 2026 in Review
Raymond James Financial reduced its Cellebrite (CLBT) stake by 32% in Q3 2026, selling an estimated $6.83M and leaving 1,087,530 shares worth $12.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1951.
Raymond James Financial first reported a position in CLBT in Q4 2024 and has held it in 8 quarters since. The position peaked at $27.7M in Q3 2025. 200 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.
- Raymond James Financial held 1,087,530 shares of Cellebrite worth $12.2M as of Q3 2026.
- Raymond James Financial sold 512,930 Cellebrite shares in Q3 2026, an estimated $6.83M.
- Cellebrite made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #1951 holding.
- Raymond James Financial first reported a position in Cellebrite in Q4 2024 and has held it in 8 quarters since.
- Raymond James Financial's Cellebrite position peaked at $27.7M in Q3 2025.
- 200 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.